Abstract
Cancer is a genetic disease, affecting many people worldwide. Chemotherapy is routinely used for cancer treatment. However, this therapeutic approach is not always effective due to the development of cell resistance and toxic effects. Plants are a reservoir of natural chemicals with chemoprotective potential against cancer and with low adverse effects. While some drugs from natural origin are currently used for cancer treatment, others are being studied. Among the compounds isolated from plants, sesquiterpene lactones are very promising anticancer agents, which are widely being studied in different models of cancer in vitro and in vivo, and some clinical trials are being performed. Sesquiterpene lactones are very attractive compounds to be used as antitumoral therapy due to the diverse mechanisms of action through which they exert their effects. Among such mechanisms are their capacity to interfere with the generation of reactive oxygen species, the epigenetic modulation of gene expression, the targeting of the sarco-/endoplasmic reticulum calcium ATPase pump, and the activation of the NF-kB and the p53 signaling pathways. The latter mechanisms could be important to reduce the development of drug resistance by tumor cells. Sesquiterpene lactones can also inhibit angiogenesis and metastasis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- ALCLs:
-
Anaplastic large cell lymphomas
- ALL:
-
Acute lymphoblastic leukemia
- AML:
-
Acute myeloid leukemia
- APL:
-
Acute promyelocytic leukemia
- Bax:
-
Apoptosis regulator BAX
- Bcl- 2:
-
B-cell CLL/lymphoma 2
- Bid:
-
BH3 interacting domain death agonist
- BL:
-
Burkitt lymphoma
- BZLF1:
-
Human herpes virus (E′stein-Barr virus) gene
- Caspases:
-
Cysteine aspartate-specific proteases
- CCRF-CEM cells:
-
Cellosaurus acute lymphoblastic leukemia cell line
- CCRF/ADR 5000:
-
Cellosaurus cell line, a doxorubicin-resistant sub-line derived from drug-sensitive, parental CCRF-CEM cells
- Cdc2:
-
Cell division control protein 2
- c-FLIP:
-
Cellular FLICE-like inhibitory protein
- CLL:
-
Chronic lymphocytic leukemia
- CML:
-
Chronic myeloid leukemia
- c-Src:
-
Proto-oncogene tyrosine-protein kinase
- C/EBP:
-
CHOP homologus protein
- GADD 153:
-
DNA damage inducible gene 153
- DU-145:
-
Human prostate carcinoma cell line
- EGFR:
-
EGFR/PI3K/Akt signaling pathway
- EBV:
-
Raji cell line: Epstein Barr virus (EBV)-positive Burkitt lymphoma (BL) cell line
- ER:
-
Endoplasmic reticulum
- ERK:
-
Extracellular signal-regulated kinase
- HDAC1:
-
Histone deacetylase 1
- HeLa:
-
Immortal cell line
- HepG2:
-
Human liver cancer cell line
- HIN-1:
-
Histidine nucleotide-binding protein 1
- HL:
-
Hodgkin lymphoma
- HL-60 :
-
Acute myeloid leukemia
- HSCs:
-
Healthy hematopoietic stem cells
- HT 29:
-
Human colorectal adenocarcinoma
- CML:
-
Human chronic myeloid leukemia (CML) K562 cells
- HL:
-
Human leukemia HL-60 cells
- IkB:
-
Inhibitor of NF-kB
- IKK:
-
NF-κB kinase
- JNK:
-
C-Jun N-terminal kinase
- Jun B:
-
Transcription factor of the tyrosine receptor kinase PDGF-Rβ
- LSCs:
-
Leukemic stem cells
- MAPK:
-
Mitogen activated protein kinases
- MCF-7:
-
Breast cancer cells
- MCF7:
-
Human breast adenocarcinoma cell line
- MDA-MB 435:
-
Melanoma cell line
- MDA-MB-231:
-
Human breast cancer cell line
- MDM2:
-
Mouse double minute 2 homolog protein
- MIA-PaCa-2 cells:
-
Human pancreatic carcinoma cell lines
- MDR P-gp CEM/ADR5000 cells:
-
Multidrug-resistant P-gp over expressing CEM/ADR5000 leukemic cells
- NF-κB:
-
Nuclear factor kappa-light-chain-enhancer of activated B cells
- NHL:
-
Non-Hodgkin lymphoma
- NIH/3T3:
-
Normal fibroblast cell line
- NPM-ALK:
-
Nucleophosmin-anaplastic lymphoma kinase
- p21:
-
Protein P21
- P-38:
-
Protein kinase P-38
- p53:
-
Protein P53
- PARP 1:
-
Poly-(ADP-ribose) polymerase1
- PBMC:
-
Peripheral blood mononuclear cells
- PC-3:
-
Human prostate grade IV adenocarcinoma cell line
- PDGF-Rβ:
-
Beta-type platelet-derived growth factor receptor
- PI3K:
-
Phosphatidylinositol-3-kinase
- PKCα:
-
Protein kinase C alpha
- PKCβII:
-
Protein kinase β
- RIPK1:
-
Receptor interacting protein kinase 1
- ROS:
-
Reactive oxygen species
- SW872:
-
Cellosaurus cell line SW 872, liposarcoma
- SW982:
-
Cellosaurus cell line SW 982, biphasic synovial sarcoma
- TE-671:
-
Cellosaurus cell line T-671, a human rhabdomyosarcoma
- SER:
-
Sarcoplasmic/endoplasmic reticulum
- SERCA:
-
Sarco/endoplasmic reticulum calcium ATPase
- Smac/Diablo:
-
Mitochondria-derived activator of caspases
- SMMC-7721:
-
Human hepatocarcinoma cell line
- STAT:
-
Signal transducer and activator of transcription
- TNFα:
-
Tumor necrosis factor-α
- TRAIL:
-
TNF-related apoptosis-inducing ligand
- U251MG:
-
Glioblastoma cell line
- U937:
-
Histiocytic lymphoma cell line
- Ub:
-
Ubiquitin
- UPR:
-
Unfolded protein response
- Walker-256:
-
Rat breast carcinoma cell line
References
Adekenov SM (2016) Chemical modification of arglabin and biological activity of its new derivatives. Fitoterapia 110:196–205
Anfosso L, Efferth T, Albini A et al (2006) Microarray expression profiles of angiogenesis-related genes predict tumor cell response to artemisinins. Pharmacogenomics J 6:269–278
Armitage JO (2012) The aggressive peripheral T-cell lymphomas: update on diagnosis, risk stratification and management. Am J Hematol 87:511–519
Balunas MJ, Kingborn AD (2005) Drug discovery from medicinal plants. Life Sci 78:431–441
Bosio C, Tomasoni G, Martínez R et al (2015) Cytotoxic and apoptotic effects of leptocarpin, a plant-derived sesquiterpene lactone, on human cancer cell lines. Chem Biol Interact 242:415–421
Bujnicki T, Wilczek C, Schomburg C et al (2012) Inhibition of Myb-dependent gene expression by the sesquiterpene lactone mexicanin-I. Leukemia 26(4):615–622
Carlisi D, D’Anneo A, Angileri L et al (2011) Parthenolide sensitizes hepatocellular carcinoma cells to TRAIL by inducing the expression of death receptors through inhibition of STAT3activation. J Cell Physiol 226:1632–1641
Carlisi D, Buttitta G, Di Fiore R et al (2016) Parthenolide and DMAPT exert cytotoxic effects on breast cancer stem-like cells by inducing oxidative stress, mitochondrial dysfunction and necrosis. Cell Death Dis 7(4):e2194
Chabner BA, Amrein PC, Druker BJ et al (2006) Antineoplastic agents. In: Goodman, Gilman’s (eds) The pharmacological basis of the therapeutics, 11th edn. The McGraw-Hill Companies Inc, New York, pp 1731–1755
Chen HH, Zhou HJ, Wu GD et al (2004) Inhibitory effects of artesunate on angiogenesis and on expressions of vascular endothelial growth factor and VEGF receptor KDR/flk-1. Pharmacology 71:1–9
Cho JY, Kim AR, Jung JH et al (2004) Cytotoxic and pro-apoptotic activities of cynaropicrin, a sesquiterpene lactone on the viability of leukocyte cancer cell lines. Eur J Pharmacol 492:85–94
Christensen SB, Skytte DM, Denmeade SR et al (2009) A trojan horse in drug development: targeting of thapsigargins towards prostate cancer cells. Anti Cancer Agents Med Chem 9:276–294
Cragg GM, Grothaus PG, Newman DJ (2009) Impact of natural products on developing new anti-cancer agents. Chem Rev 109:3012–3043
De Ford C, Ulloa JL, Catalán CA et al (2015) The sesquiterpene lactone polymatin B from Smallanthus sonchifolius induces different cell death mechanisms in three cancer cell lines. Phytochemistry 117:332–339. https://doi.org/10.1016/j.phytochem.2015.06.020
Degos L, Wang ZY (2001) All trans retinoic acid in acute promyelocytic leukemia. Oncogene 20:7140–7145. https://doi.org/10.1038/sj.onc.1204763
Del Socorro Jimenez Usuga N, Malafronte N, Osorio Durango EJ et al (2016) Phytochemical investigation of Pseudelephantopus spiralis (Less.) Cronquist. Phytochem Lett 15:256–259
Denmeade SR, Isaacs JT (2005) The SERCA pump as a therapeutic target: making a ‘smart bomb’ for prostate cancer. Cancer Biol Ther 4:14–22
Ferlay J, Soerjomataram I, Dikshit R et al (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136(5):E359–E386
Ghantous A, Gali-Muhtasib H, Vuorela H et al (2010) What made sesquiterpene lactones reach cancer clinical trials? Drug Discov Today 15:668–678
Gomes Martins G, dos Reis Lívero FA, Stolf AM et al (2015) Sesquiterpene lactones of Moquiniastrum polymorpha subsp. floccosum have antineoplastic effects in Walker-256 tumor-bearing rats. Chem Biol Interact 228:46–56
Gopal YN, Chanchorn E, Van Dyke MW (2009) Parthenolide promotes the ubiquitination of MDM2 and activates p53 cellular functions. Mol Cancer Ther 8:552–562
Guzman ML, Rossi RM, Karnischky L et al (2005) The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells. Blood 105:4163–4169
Guzman ML, Rossi RM, Neelakantan S et al (2007) An orally bioavailable parthenolide analog selectively eradicates acute myelogenous leukemia stem and progenitor cells. Blood 110:4427–4435
Hoffmann R, von Schwarzenberg K, Lopez-Anton N et al (2011) Helenalin by passes Bcl-2-mediated cell death resistance by inhibiting NF-kappaB and promoting reactive oxygen species generation. Biochem Pharmacol 82:453–463
Hopfinger G, Griessl R, Sifft E et al (2012) Novel treatment avenues for peripheral T-cell lymphomas. Expert Opin Drug Discovery 7:1149–1163
Huang CC, Lo CP, Chiu CY et al (2010) Deoxyelephantopin, a novel multifunctional agent, suppresses mammary tumour growth and lungmetastasis and doubles survival time in mice. Br J Pharmacol 159:856–871
Hung JY, Hsu YL, Ni WC et al (2010) Oxidative and endoplasmic reticulum stress signaling are involved in dehydrocostuslactone-mediated apoptosis in human non-small cell lungcancer cells. Lung Cancer 68:355–365
Idris AI, Libouban H, Nyangoga H et al (2009) Pharmacologic inhibitors of IkappaB kinase suppress growth and migration of mammary carcinosarcoma cells in vitro and prevent osteolyticbone metastasis in vivo. Mol Cancer Ther 8:2339–2347
Jaffe ES (2009) The 2008 WHO classification of lymphomas: implications for clinical practice and translational research. Hematology Am Soc Hematol Educ Program:523–531. https://doi.org/10.1182/asheducation-2009.1.523
JoungYoun U, Miklossy G, Chai X et al (2014) Bioactive sesquiterpene lactones and other compounds isolated from Vernonia cinerea. Fitoterapia 93:194–200
Kempema AM, Widen JC, Hexum JK et al (2015) Synthesis and antileukemic activities of C1–C10-modifiedparthenolide analogues. Bioorg Med Chem 23:4737–4745
Kiss I, Unger C, Huu CN et al (2015) Lobatin B inhibits NPM/ALK and NF-κB attenuating anaplastic-large cell-lymphomagenesis and lymph endothelial tumour in travasation. Cancer Lett 356:994–1006
Kreuger M, Grootjans S, Biavatti MW et al (2012) Sesquiterpene lactones as drugs with multiple targets in cancer treatment: focus on parthenolide. Anti-Cancer Drugs 23(9):883–896
Krysko DV, Vandenabeele P (2009) Part I-molecular mechanisms of phagocytosis of dying cells. In: Krysko DV, Vandenabeele P (eds) Phagocytosis of dying cells from molecular mechanisms to human diseases. Springer, Dordrecht, pp 3–31
Krysko DV, Brouckaert G, Kalai M et al (2003) Mechanisms of internalization of apoptotic and necrotic L929 cells by amacrophage cell line studied by electron microscopy. J Morphol 258:336–345
Kweon SH, Song JH, Kim HJ et al (2015) Induction of human leukemia cell differentiation via PKC/MAPK pathways by arsantin, a sesquiterpene lactone from Artemisia santolina. Arch Pharm Res 38(11):2020–2028. https://doi.org/10.1007/s12272-015-0609-4
Lee J, Hwangbo C, Lee JJ et al (2010) The sesquiterpene lactone eupatolide sensitizes breast cancer cells to TRAIL through down-regulationof c-FLIP expression. Oncol Rep 23:229–237
Li Y, Zhang Y, Fu M et al (2012) Parthenolide induces apoptosis and lytic cytotoxicity in Epstein-Barr virus-positive Burkitt lymphoma. Mol Med Rep 6:477–482
Li H, Li M, Wang G et al (2016) EM23, a natural sesquiterpene lactone from Elephantopus mollis, induces apoptosis in human myeloid leukemia cells through thioredoxin- and reactive oxygen species-mediated signaling pathways. Front Pharmacol. https://doi.org/10.3389/fphar.2016.00077
Liu Z, Liu S, Xie Z et al (2009) Modulation of DNA methylation by a sesquiterpene lactone parthenolide. J Pharmacol Exp Ther 329:505–514
Liu W, Wang X, Sun J et al (2017) Parthenolide suppresses pancreatic cell growth by autophagy-mediated apoptosis. Onco Targets Ther 10:453–461
Lohberger B, Rinner B, Stuendl N et al (2013) Sesquiterpene lactones downregulate G2/M cell cycle regulator proteins and affect the invasive potential of human soft tissue sarcoma cells. PLoS One 8:1–9
Mahalingam D, Wilding G, Denmeade S et al (2016) Mipsagargin, a novel thapsigargin-based PSMA-activated prodrug: results of a first-in-man phase I clinical trial in patients with refractory, advanced or metastatic solid tumours. Br J Cancer 114:986–994. https://doi.org/10.1038/bjc.2016.72
Marin GH, Mansilla E, Ciocchini S et al (2013) Sesquiterpene lactone extract from native American herbs demonstrated antineoplastic activity against non Hodgkin lymphoma cells. Annalen der Chemi Forschung 1(2):50–55
Martino R, Beer MF, Anesini C et al (2015) Sesquiterpene lactones from Ambrosia spp.are active against a murine lymphoma cell line by inducing apoptosis and cell cycle arrest. Toxicol In Vitro 29:1529–1536
Merfort I (2011) Perspectives on sesquiterpene lactones in inflammation and cancer. Curr Drug Targets 12:1560–1573
Muñoz Acuña U, Shen Q, Ren Y et al (2013) Goyazensolide induces apoptosis in cancer cells in vitro and in vivo. Int J Cancer Res 9(2):36–53. https://doi.org/10.3923/ijcr.2013.36.53
Nakase I, Gallis B, Takatani-Nakase T et al (2009) Transferrin receptor-dependent cytotoxicity of artemisinin–transferrin conjugates on prostate cancer cells and induction of apoptosis. Cancer Lett 274:290–298
Oh GS, Pae HO, Chung HT et al (2004) Dehydrocostuslactone enhances tumor necrosis factor-alpha-inducedapoptosis of human leukemia HL-60 cells. Immunopharmacol Immunotoxicol 26:163–175
Oka D, Nishimura K, Shiba M et al (2007) Sesquiterpene lactone parthenolide suppresses tumor growth in axenograft model of renal cell carcinoma by inhibiting the activation of NF-kappaB. Int J Cancer 120:2576–2581
Ordóñez PE, Sharma KK, Bystrom LM et al (2016) Dehydroleucodine, a sesquiterpene lactone from Gynoxys verrucosa, demonstrates cytotoxic activity against Human Leukemia Cells. J Nat Prod 79(4):691–696
Quynh D NT, Christensen SB (2015). Thapsigargin, Origin, Chemistry, Structure-Activity Relationships and Prodrug Development. Curr Pharm Des. 21(38):5501–5517
Ralstin MC, Gage EA, Yip-Schneider MT et al (2006) Parthenolide cooperates with NS398 to inhibit growth of humanhepatocellular carcinoma cells through effects on apoptosis and G0-G1 cellcycle arrest. Mol Cancer Res 4:387–399
Rozenblat S, Grossman S, Bergman M et al (2008) Induction of G2/M arrest and apoptosis by sesquiterpene lactones inhuman melanoma cell lines. Biochem Pharmacol 75:369–382
Saeed M, Jacob S, Sandjo LP et al (2015) Cytotoxicity of the sesquiterpene lactones neoambrosin and damsin from Ambrosia maritime against multidrug-resistant cancer cells. Front Pharmacol 6:267. https://doi.org/10.3389/fphar.2015.00267
Shukla N, Freeman N, Gadsdon P et al (2001) Thapsigargin inhibits angiogenesis in the rat isolated aorta:studies on the role of intracellular calcium pools. Cardiovasc Res 49:681–689
Singh NP, Panwar VK (2006) Case report of a pituitary macro adenoma treated with artemether. Integr Cancer Ther 5:391–394
Sturgeon CM, Craig K, Brown C et al (2005) Modulation of the G2 cell cycle checkpoint by sesquiterpene lactones psilostachyins A and C isolated from the common ragweed Ambrosia artemisiifolia. Planta Med 71(10):938–943
Sun Y, St Clair DK, Xu Y et al (2010) A NADPH oxidase dependent redox signaling pathway mediates the selective radio sensitization effect of parthenolide in prostate cancer cells. Cancer Res 70:2880–2890
Sweeney CJ, Mehrotra S, Sadaria MR et al (2005) The sesquiterpene lactone parthenolide in combination with docetaxel reduces metastasis and improves survival in a xenograft model of breast cancer. Mol Cancer Ther 4:1004–1012
Takeuchi O, Akira S (2010) Pattern recognition receptors and inflammation. Cell 140:805–820
Villagomez R, Rodrigo GC, Collado IG et al (2013) Multiple anticancer effects of damsin and coronopilin isolated from Ambrosia arborescens on cell cultures. Int J Anticancer Res 33:3799–3806
Wang GW, Qin JJ, Cheng XR et al (2014) Inula sesquiterpenoids: structural diversity, cytotoxicity and anti-tumor activity. Expert Opin Investig Drugs 23(3):317–345. https://doi.org/10.1517/13543784.2014.868882
World Health Organization (WHO) (2005) Preventing chronic diseases: a vital investment. Geneva: WHO Global report. http://www.who.int/chp/chronic_disease_report/en/. Accessed 14 Aug 2017
World Health Organization (WHO) (2017) http://www.who.int/cancer/en/. Accessed 14 Aug 2017
Yang YJ, Yao J, Jin X et al (2016) Sesquiterpenoids and tirucallane triterpenoids from the roots of Scorzonera divaricata. Phytochemistry 124:86–98
Yip-Schneider MT, Nakshatri H, Sweeney CJ et al (2005) Parthenolide and sulindac cooperate to mediate growth suppression and inhibit the nuclear factor-kB pathway in pancreatic carcinoma cells. Mol Cancer Ther 4:587–594
Zeisig BB, Kulasekararaj AG, Mufti GJ et al (2012) Snap shot: acute myeloid leukemia. Cancer Cell 22:691–698. https://doi.org/10.1016/j.ccr.2012.10.017
Zhang C, Lu T, Wang GD et al (2016) Costunolide, an active sesquiterpene lactone, induced apoptosis via ROS-mediated ER stress and JNK pathway in human U2OS cells. Biomed Pharmacother 80:253–259
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Anesini, C.A., Alonso, M.R., Martino, R.F. (2018). Antiproliferative and Cytotoxic Activities. In: Sülsen, V., Martino, V. (eds) Sesquiterpene Lactones. Springer, Cham. https://doi.org/10.1007/978-3-319-78274-4_13
Download citation
DOI: https://doi.org/10.1007/978-3-319-78274-4_13
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-78273-7
Online ISBN: 978-3-319-78274-4
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)